AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Dermatitis refers to skin inflammation. Types include atopic dermatitis (eczema), contact dermatitis, seborrheic dermatitis, and dishydrotic dermatitis. Symptoms may include dry skin, itchiness ...

POD is an inflammatory facial eruption ... Granulomatous periorificial dermatitis (GPOD) consists of monomorphic small papules affecting perinasal, perioral, and periocular skin and is typically ...

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by dry, itchy, and inflamed skin. It is part of a group of diseases known as inflammatory skin diseases, which also ...

Now that there is compelling evidence that seborrheic dermatitis is best characterized as an inflammatory disease, the use of topical antifungals, despite the efficacy they offer, should be placed ...

Emollients and topical corticosteroids are frequently used to reduce inflammation and itching in acute flares. Asteatotic eczema is a common type of dermatitis that occurs as a result of dry skin.

Comorbid chronic inflammatory diseases (CIDs) influence the prognosis of alopecia areata (AA), according to a researc ...

• Topical treatments: Over-the-counter 1% hydrocortisone cream can help with mild flare-ups. For more severe cases, pediatricians may prescribe stronger topical steroids or calcineurin inhibitors.

Asthma, atopic dermatitis or Hashimoto's thyroiditis as concomitant diseases are risk factors for clinical features associated with a poor prognosis in circular hair loss, also known as alopecia ...

Even dogs can suffer from dermatitis. That's right: just like for us humans, it is a rather common skin disease.

Having asthma, Hashimoto’s thyroiditis or atopic dermatitis in addition to alopecia areata raised the odds for early-onset, severe and prolonged alopecia areata, according to a research letter ...

Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like SAR444656 and amlitelimab in development.